Jiangxi Sanxin Medtec Co., Ltd. engages in the research and development, manufacture, sale, and service of medical devices in China and internationally. It offers blood purification products, such as centralized dialysate supply systems, hemodialysis water preparation systems, hemodialysis machines, nursing kits for dialysis, central venous catheter packs, arteriovenous spikes, accessories tubing for HDF, dialysate filters, hemodialysis powders and concentrates, hollow fiber hemodialyzers, sterile hemodialysis blood circuits, and tubing sets for hemodialysis. The company also provides infusion and transfusion products, including light-resistant infusion sets, TPE precise filter infusion sets, auto stop fluid precise filter infusion sets, transfusion sets, catheter infusion sets, and precise filter light resistant infusion sets; injections consisting of insulin, dispenser, sterile, and auto-disable syringes; and syringes for fixed dose immunization, hypodermic needles, needleless injection systems, and pneumatic syringes. In addition, it offers indwelling catheter products comprising straight, Y-type, and closed intravenous (IV) catheters; and positive pressure IV catheters, central venous catheter packs, extension tubes with three-way valve, and heparin caps. Further, the company offers blood microembolus filters, disposable extracorporeal circulation tubing kits, cold cardioplegic solution perfusion apparatus, blood containers, medical surgical face masks, disinfectants, and alcohol pads. Jiangxi Sanxin Medtec Co., Ltd. was founded in 1997 and is based in Nanchang, China.
Jiangxinxin Medtec Dividend Announcement
• Jiangxinxin Medtec announced a semi annually dividend of ¥0.10 per ordinary share which will be made payable on 2024-09-09. Ex dividend date: 2024-09-09
• Jiangxinxin Medtec annual dividend for 2024 was ¥0.25
• Jiangxinxin Medtec annual dividend for 2023 was ¥0.20
• Jiangxinxin Medtec's trailing twelve-month (TTM) dividend yield is 3.08%
• Jiangxinxin Medtec's payout ratio for the trailing twelve months (TTM) is 82.34%
• Jiangxinxin Medtec's dividend growth over the last five years (2018-2023) was 14.64% year
Jiangxinxin Medtec Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-09 | ¥0.10 | semi annually | 2024-09-09 |
2024-04-25 | ¥0.15 | semi annually | 2024-04-25 |
2023-04-24 | ¥0.20 | semi annually | 2023-04-24 |
2022-04-29 | ¥0.15 | semi annually | 2022-04-29 |
2021-04-29 | ¥0.20 | semi annually | 2021-04-29 |
2020-05-13 | ¥0.10 | semi annually | 2020-05-13 |
2019-05-06 | ¥0.16 | semi annually | 2019-05-06 |
2018-06-04 | ¥0.10 | semi annually | 2018-06-04 |
2017-04-27 | ¥0.10 | semi annually | 2017-04-27 |
2016-04-01 | ¥0.20 | semi annually |
Jiangxinxin Medtec Dividend per year
Jiangxinxin Medtec Dividend growth
Jiangxinxin Medtec Dividend Yield
Jiangxinxin Medtec current trailing twelve-month (TTM) dividend yield is 3.08%. Interested in purchasing Jiangxinxin Medtec stock? Use our calculator to estimate your expected dividend yield:
Jiangxinxin Medtec Financial Ratios
Jiangxinxin Medtec Dividend FAQ
Other factors to consider when evaluating Jiangxinxin Medtec as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Jiangxinxin Medtec stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Jiangxinxin Medtec's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Jiangxinxin Medtec publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Jiangxinxin Medtec distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Jiangxinxin Medtec are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Jiangxinxin Medtec sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Jiangxinxin Medtec distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Jiangxinxin Medtec declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Jiangxinxin Medtec's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Jiangxinxin Medtec's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.